Andrew Lo, 10% Owner at Axovant Sciences Ltd. (AXON), bought 10,000,000 shares at $1.00 ($10.0M) on 2018-12-18, disclosed to the SEC on 2018-12-20.
Open-market purchase of $10.0M AXON by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | BUY | 2022-01-03 | $99K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |